Skip to main content
Premium Trial:

Request an Annual Quote

Xenon Genetics Identifies Epilepsy and Iron Regulation Genes

SAN FRANCISCO, Dec. 19 - Xenon Genetics said on Wednesday that it had discovered a gene related to epilepsy and one that is associated with iron metabolism regulation.

 

The epilepsy gene was found through genetic analysis of families with a form of epilepsy called idiopathic generalized epilepsy. The finding was then validated clinically in humans, according to the Vancouver, B.C.-based company.

 

The second gene was identified through an animal model and validated as an iron metabolism regulator in humans.

 

Xenon said both genes were found to be drug targets for possible therapies for treating iron disorders and epilepsy.

 

"With these discoveries, Xenon's portfolio of validated genes associated with important biological pathways and human disease now stands at 13," Frank Holler, CEO of Xenon, said in a statement. "This growing pipeline of new genes and drug targets provides an excellent springboard from which we can identify and develop new genetically derived drugs."

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.